A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1
Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
OH2 Oncolytic Viral Therapy in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Expanded Access of Vigil in Solid Tumors
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
AO-176 in Multiple Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)
- Status
- TERMINATED
- Phase
- PHASE2